Stock Data
$1.81 (6.06%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
FINANCIAL SERVICES
Industry
INSURANCE BROKERS
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Ethos is guiding full-year revenue to $727 million to $731 million, roughly 88% growth, and the board authorized a $100 million buyback months after the IPO. Direct Channel revenue jumped 131% to $116.5 million on 107,847 new policies activated. Keep an eye on the stock as that guidance gets tested.
26 Articles
Our top personal finance-related articles today. Your wallet will thank you later.
